Ready Reporter Virus™ Kits – Product Information

Your Fastest Microneutralization Assay

Ready Reporter Virus (RRV) kits offer a powerful blend of speed and biological relevance that’s unlike anything you’ve used before, all in a convenient thaw-and-use package. Results are ready in hours—10 times faster than traditional PRNT assays, which read out in days. Now you can generate neutralization data any day of the week.

Unlike binding assays or cell-free fusion assays, RRV kits use live cells and authentic viral antigen to generate functional data. The kits’ thaw-and-use target cells eliminate the need for cell culture and sterile technique, maximizing efficiency and eliminating the risks associated with passaging your own cells. The kits’ non-replicative quickly activate an optical reporter upon cell entry, eliminating the lengthy wait for gene expression.

RRV kits work seamlessly with standard equipment and automated systems, making them perfect for high-throughput environments. Because they require minimal equipment and training, RRV kits make efficient use of your team’s time.

Ready Reporter Virus kits include pseudotyped virus particles and permissive target cells. The particles exhibit viral surface proteins embedded in a lipid bilayer on a lentivirus core filled with reporter enzymes. The cells express virus-specific receptors and/or binding factors and contain inactive reporter dye.

Features

✔ Same-day results

✔ No tissue culture

✔ Real antigen & live cells

✔ Safe in BSL-2

✔ Easy to automate

Product Offerings — Buy Neutralization Assay Kits

Ready Reporter Virus (RRV) kits are available now for select SARS-CoV-2 variants and influenza strains. Stay tuned for new RRV kit releases and additional optical readout options. Contact us any time for more information or to join our mailing list.
Catalog No. Virus (Subtype) Variant or Strain Target Cells
RRK-702 SARS-CoV-2 D614G HEK-ACE2
RRK-1701 SARS-CoV-2 JN.1 [16MPLF] HEK-ACE2
RRK-1213
Coming soon!
Influenza A (H1N1) Wisconsin/67/2022 MDCK-derived
RRK-1215 Influenza A (H3N2) Massachusetts/18/2022 MDCK-derived
RRK-1218 Influenza A (H5N1) Texas/37/2024 MDCK-derived
RRK-1001 Vesicular Stomatitis Virus Indiana HEK-293T

Follow the link below to view individual product details and order an RRV Kit today. For a limited time, you can request a free sample.

How Ready Reporter Virus Kits Generate Biologically Relevant Results Safely

Ready Reporter Virus (RRV) kits use a pseudovirus system that models authentic viral entry in the absence of viral genetic material. Each kit includes non-replicative, pseudotyped reporter virus particles that display relevant viral envelope proteins, along with permissive target cells pre-loaded with reporter dye. When the viral particles fuse with the cell membrane, they deliver a reporter enzyme. The enzyme triggers a change in a fluorescent substrate inside the cell (luminescent substrates in development). This optical signal allows you to quantify neutralizing activity in test samples.
Panel 1: Neutralizing antibody binds to RRV particle, blocking it from binding the host cell receptor. Panel 2: With no neutralization, the particle binds the host cell receptor, fuses with the cell membrane, and releases reporter enzyme into the cell. The enzyme cleaves a reporter dye, activating it and enabling signal detection.

Reliable Results for Viral Entry Inhibition

Beyond speed benefits, Ready Reporter Virus (RRV) kits deliver exceptional reproducibility. Demonstrated in the graphs below, RRV kits generate similar neutralization curves from lot to lot (left) and between users (right). We observe similar neutralization results from different users working on different days. Notably, these users differed in their experience levels, ranging from a PhD scientist to a junior research associate with minimal training.

Our ISO 9001 certified quality systems ensure the consistency and reliability you need to support vaccine development, antibody discovery and development, and basic research. RRV kits are built upon decades of expertise in virology research, product development, and customer service. Our pseudotyped Reporter Virus Particles have already been adopted by over 100 labs worldwide for research on diverse pathogens.

Neutralization results. Testing combinations of 2 RRV lots and 2 cell lots demonstrate lot-to-lot reproducibility (left). NT50 results are consistent across 3 users, ranging from 0.33 to 0.50 micrograms per milliliter (right).

Example Applications Across Vaccine Development, Antibody Discovery, and Research

Vaccine Development

  • Accelerate go/no-go decisions with fast neutralization readouts
  • Reduce overhead by eliminating cell culture
    and BSL-3 containment
  • Streamline workflows with automation
    compatibility

Academic Research

  • Maximize output with lean teams and minimal personnel
  • Access expert support whether you’re new to virology or have advanced needs
  • Focus on research, not assay optimization
 

Antibody Discovery

  • Generate functional screening data for B-cell clones & antibody variants with minimal setup
  • Support early-stage lead selection and potency ranking
  • Use one assay from lead discovery through lot release testing

Application Highlight: Accelerating Antibody Discovery and Development

Ready Reporter Virus (RRV) kits streamline functional screening workflows for antibody discovery, enabling rapid, biologically relevant assessment of neutralizing activity. By eliminating cell passaging and reducing assay time to under a day, RRV kits enable function-forward screening for single clones. They allow researchers to test more candidates, iterate faster, and make lead decisions earlier in the development cycle.

Designed for standard lab equipment and automation platforms, RRV kits support high-throughput screening across multiple sample formats: B-cell supernatants, hybridoma libraries, engineered antibody variants, bacterial extracts, phage display, and more. The functional readouts provide critical data for lead selection, GMP potency assays, and regulatory submissions, making them an ideal tool for biotech teams focused on therapeutic innovation and speed-to-market.

High-throughput screening of viral fusion inhibitors in 96-well assay format. Test molecules were combined with RRV particles and added to target cells. After 1-3 hour incubation, data was analyzed by flow cytometry. Results identify 5 functional inhibitors and several non-inhibitors.

A SARS-CoV-2 RRV kit was used to screen numerous scFvs from E. coli for viral fusion inhibition. Gray line shows fluorescence background level. Solid orange line represents the mean, dotted lines show one standard deviation, and dashed lines show three standard deviations.

Frequently Asked Questions 

Contact Us